[1] Beltramini GA, Massarelli O, Demarchi M, et al. Is neck dissection needed in squamous-cell carcinoma of the maxillary gingiva, alveolus, and hard palate? A multicentre Italian study of 65 cases and literature review [J]. Oral Oncol, 2012, 48(2): 97-101.
[2] Morris LG, Patel SG, Shah JP, et al. High rates of regional failure in squamous cell carcinoma of the hard palate and maxillary alveolus [J]. Head Neck, 2011, 33(6): 824-830.
[3] Simental AA, Johnson JT, Myers EN. Cervical metastasis from squamous cell carcinoma of the maxillary alveolus and hard palate [J]. Laryngoscope, 2006, 116(9): 1682-1684.
[4] Montes DM, Schmidt BL. Oral maxillary squamous cell carcinoma: management of the clinically negative neck [J]. J Oral Maxillofac Surg, 2008, 66(4): 762-766.
[5] Sagheb K, Taylor KJ, Al-Nawas B, et al. Cervical metastases of squamous cell carcinoma of the maxilla: a retrospective study of 25 years [J]. Clin Oral Investig, 2014, 18(4):1221-1227.
[6] Lin HW, Bhattacharyya N. Survival impact of nodal disease in hard palate and maxillary alveolus cancer [J]. Laryngoscope, 2009, 119(2): 312-315.
[7] Mourouzis C, Pratt C, Brennan PA. Squamous cell carcinoma of the maxillary gingiva, alveolus, and hard palate: is there a need for elective neck dissection? [J]. Br J Oral Maxillofac Surg, 2010, 48(5): 345-348.
[8] Leusink FK, van Es RJ, de Bree R, et al. Novel diagnostic modalities for assessment of the clinically node-negative neck in oral squamous-cell carcinoma [J]. Lancet Oncol, 2012, 13(12): e554-e561.
[9] Poeschl PW, Seemann R, Czembirek C, et al. Impact ofelective neck dissection on regional recurrence and survival in cN0 staged oral maxillary squamous cell carcinoma [J]. Oral Oncol, 2012, 48(2): 173-178.
[10] Zwetyenga N, Miquel L, Garuet A, et al. Treatment of squamous-cell carcinoma of the upper gum and the hard palate [J]. Rev Stomatol Chir Maxillofac, 2006, 107(2): 80-85.
[11] Binahmed A, Nason RW, Hussain A, et al. Treatment outcomes in squamous cell carcinoma of the maxillary alveolus and palate: a population-based study [J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2008, 105(6): 750-754.
[12] Kruse AL, Gratz KW. Cervical metastases of squamous cell carcinoma of the maxilla: a retrospective study of 9 years [J]. Head Neck Oncol, 2009, 1(1):1-8.
[13] Lubek J, El-Hakim M, Salama AR, et al. Gingival carcinoma: retrospective analysis of 72 patients and indications for elective neck dissection [J]. Br J Oral Maxillofac Surg, 2011, 49(3): 182-185.
[14] Feng Z, Li JN, Li CZ, et al. Elective neck dissection versus observation for cN0 neck of squamous cell carcinoma primarily located in the maxillary gingiva and alveolar ridge: a retrospective study of 129 cases [J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2013, 116(5): 556-561.
[15] Yang Z, Deng R, Sun G, et al. Cervical metastases from squamous cell carcinoma of hard palate and maxillary alveolus: A retrospective study of 10 years [J]. Head Neck, 2014,36(7):969-975.
[16] Ogura I, Kurabayashi T, Sasaki T, et al. Maxillary bone invasion by gingival carcinoma as an indicator of cervical metastasis [J]. Dentomaxillofac Radiol, 2003, 32(5): 291-294.
[17] Shah J, Andersen P. Evolving role of modifications in neck dissection for oral squamous carcinoma [J]. Br J Oral Maxillofac Surg, 1995, 33(1): 3-8.
[18] de Bondt RB, Nelemans PJ, Hofman PA, et al. Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USgFNAC, CT and MR imaging [J]. Eur J Radiol, 2007, 64(2): 266-272.
[19] Foote RL, Olsen KD, Davis DL, et al. Base of tongue carcinoma: patterns of failure and predictors of recurrence after surgery alone [J]. Head Neck, 1993, 15(4): 300-307.
[20] Leemans CR, Tiwari R, Nauta JJ, et al. Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor [J]. Cancer, 1994, 73(1): 187-190.
[21] Argiris A, Karamouzis MV, Raben D, et al. Head and neck cancer [J]. Lancet, 2008, 371(9625): 1695-1709.
[22] Shingaki S, Suzuki I, Nakajima T, et al. Computed tomographic evaluation of lymph node metastasis in head and neck carcinomas [J]. J Craniomaxillofac Surg, 1995, 23(4): 233-237.
[23] van den Brekel M, Castelijns JA, Snow GB. The size of lymph nodes in the neck on sonograms as a radiologic criterion for metastasis: how reliable is it? [J]. AJNR Am J Neuroradiol, 1998, 19(4): 695-700.
[24] Lonneux M, Hamoir M, Reychler H, et al. Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study [J]. J Clin Oncol, 2010, 28(7): 1190-1195.
[25] Lee JC, Kim JS, Lee JH, et al. F-18 FDG-PET as a routine surveillance tool for the detection of recurrent head and neck squamous cell carcinoma [J]. Oral Oncol, 2007, 43(7): 686-692.
[26] Govers TM, Hannink G, Merkx MA, et al. Sentinel node biopsy for squamous cell carcinoma of the oral cavity and oropharynx: a diagnostic meta-analysis [J]. Oral Oncol, 2013, 49(8): 726-732.
[27] Shoaib T, Soutar DS, MacDonald DG, et al. The accuracy of head and neck carcinoma sentinel lymph node biopsy in the clinically N0 neck [J]. Cancer, 2001, 91(11): 2077-2083.
[28] Nieuwenhuis EJ, van der Waal I, Leemans CR, et al. Histopathologic validation of the sentinel node concept in oral and oropharyngeal squamous cell carcinoma [J]. Head Neck, 2005, 27(2): 150-158.
[29] Stoeckli SJ. Sentinel node biopsy for oral and oropharyngeal squamous cell carcinoma of the head and neck [J]. Laryngoscope, 2007, 117(9): 1539-1551.
[30] Dequanter D, Shahla M, Paulus P, et al. Long term results of sentinel lymph node biopsy in early oral squamous cell carcinoma [J]. Onco Targets Ther, 2012, 6:799-802.
[31] Alkureishi LW, Burak Z, Alvarez JA, et al. Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma [J]. Ann Surg Oncol, 2009, 16(11): 3190-3210.
[32] Stoeckli SJ, Alkureishi LW, Ross GL. Sentinel node biopsy for early oral and oropharyngeal squamous cell carcinoma [J]. Eur Arch Otorhinolaryngol, 2009, 266(6): 787-793.
[33] Keski-Santti H, Kontio R, Tornwall J, et al. Sentinel lymph node biopsy or elective neck dissection for patients with oral squamous cell carcinoma? [J]. Eur Arch Otorhinolaryngol, 2008, 265 (1):13-17.
[34] Trivedi NP, Ravindran HK, Sundram S, et al. Pathologic evaluation of sentinel lymph nodes in oral squamous cell carcinoma [J]. Head Neck, 2010, 32(11): 1437-1443.
[35] Alkureishi LW, Ross GL, Shoaib T, et al. Sentinel node biopsy in head and neck squamous cell cancer: 5-year follow-up of a European multicenter trial [J]. Ann Surg Oncol, 2010, 17(9): 2459-2464.
[36] Cheng A, Schmidt BL. Management of the N0 neck in oral squamous cell carcinoma [J]. Oral Maxillofac Surg Clin North Am, 2008, 20(3): 477-497.
[37] Woolgar JA. Histological distribution of cervical lymph node metastases from intraoral/oropharyngeal squamous cell carcinomas [J]. Br J Oral Maxillofac Surg, 1999, 37(3): 175-180.
[38] Montes DM, Carlson ER, Fernandes R, et al. Oral maxillary squamous carcinoma: an indication for neck dissection in the clinically negative neck [J]. Head Neck, 2011, 33(11): 1581-1585.
[39] Umeda M, Minamikawa T, Komatsubara H, et al. En bloc resection of the primary tumour and cervical lymph nodes through the parapharyngeal space in patients with squamous cell carcinoma of the maxilla: a preliminary study [J]. Br J Oral Maxillofac Surg, 2005, 43(1): 17-22.
[40] Umeda M, Minamikawa T, Yokoo S, et al. Metastasis of maxillary carcinoma to the parapharyngeal space: rationale and technique for concomitant en bloc parapharyngeal dissection [J]. J Oral Maxillofac Surg, 2002, 60(4): 408-413.
[41] Pitman KT. Rationale for elective neck dissection [J]. Am J Otolaryngol, 2000, 21(1): 31-37.
[42] Yao M, Epstein JB, Modi BJ, et al. Current surgical treatment of squamous cell carcinoma of the head and neck [J]. Oral Oncol, 2007, 43(3): 213-223.
[43] Evans PR, Montgomery PQ, Gullane PJ. Principles and Practice of Head and Neck Surgery and Oncology [M]. Taylor & Francis, 2003.
[44] Haddadin KJ, Soutar DS, Oliver RJ, et al. Improved survival for patients with clinically T1/T2, N0 tongue tumors undergoing a prophylactic neck dissection [J]. Head Neck, 1999, 21(6): 517-525.
[45] Capote A, Escorial V, Munoz-Guerra MF, et al. Elective neck dissection in early-stage oral squamous cell carcinoma--does it influence recurrence and survival? [J]. Head Neck, 2007, 29(1): 3-11.
[46] Kaya S, Yilmaz T, Gursel B, et al. The value of elective neck dissection in treatment of cancer of the tongue [J]. Am J Otolaryngol, 2001, 22(1): 59-64.
[47] Brown JS, Bekiroglu F, Shaw RJ, et al. Management of the neck and regional recurrence in squamous cell carcinoma of the maxillary alveolus and hard palate compared with other sites in the oral cavity [J]. Head Neck, 2013, 35(2): 265-269.
[48] Weiss MH, Harrison LB, Isaacs RS. Use of decision analysis in planning a management strategy for the stage N0 neck [J]. Arch Otolaryngol Head Neck Surg, 1994, 120(7): 699-702.
[49] Dalal AJ, McLennan AS. Cervical metastases from maxillary squamous cell carcinoma: retrospective analysis and review of the literature [J]. Br J Oral Maxillofac Surg, 2013, 51(8): 702-706. |